SCHEMBL22327488

SCHEMBL22327488

NC(=O)CC(=O)Cc1cccc(F)c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.51
NR3C2 P08235 1/20 0.47
MAOB P27338 1/20 0.47
PARP10 Q53GL7 1/20 0.47
VNN1 O95497 1/20 0.46
TAAR1 Q96RJ0 2/20 0.46
PARP1 P09874 1/20 0.46
SLC1A1 P43005 2/20 0.45
RAB9A P51151 2/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
KMT2A Q03164 1/20 0.45
IDO1 P14902 2/20 0.44
AGXT P21549 2/20 0.44
SRC P12931 1/20 0.44
MAPK1 P28482 1/20 0.43
CNR2 P34972 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2029757 0.85 MAPK8 (0.52) MAPK8NR3C2MAOBPARP10TAAR1
SCHEMBL6864466 0.85 TAAR1 (0.50) MAPK8MAOBPARP10VNN1TAAR1
SCHEMBL27814786 0.84 FFAR1 (0.49) MAPK8VNN1SLC1A1RAB9AMEN1
SCHEMBL2209416 0.83 VNN1 (0.49) MAPK8MAOBVNN1TAAR1RAB9A
Hydrochloric Acid SCHEMBL1150988 0.81 TAAR1 (0.52) MAPK8MAOBPARP10VNN1TAAR1
SCHEMBL11178482 0.80 SRC (0.55) VNN1SLC1A1RAB9AMEN1KMT2A
SCHEMBL8053109 0.80 VNN1 (0.49) MAPK8MAOBPARP10VNN1TAAR1
SCHEMBL13237150 0.80 VNN1 (0.47) MAPK8MAOBVNN1TAAR1RAB9A
SCHEMBL28434907 0.80 CES1 (0.47) MAPK8VNN1RAB9AMEN1NPC1
SCHEMBL3371173 0.79 VNN1 (0.45) MAPK8VNN1TAAR1SLC1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738015-B2 1,3-diaza-spiro-[3.4]-octane derivatives Grünenthal GmbH (DE) 2020-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738015-B2 1,3-diaza-spiro-[3.4]-octane derivatives OPRK1, OPRD1, OPRL1 MAPK8 1622/4885NR3C2 47/4885MAOB 491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.